share_log

Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $92

Benzinga ·  Aug 3 06:07  · Ratings

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and raises the price target from $79 to $92.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment